Minamestane (FCE 24928) is a selective and competitive aromatase inhibitor with an IC50 value of 45.7 nM. Minamestane is promising for research of postmenopausal breast cancer[1].
References
[1] Di Salle E, et al. Novel aromatase and 5α-reductase inhibitors[J]. The Journal of Steroid Biochemistry and Molecular Biology, 1994, 49(4-6): 289-294.
